PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma

por Singh, Alok R., Joshi, Shweta, Zulcic, Muamera, Alcaraz, Michael, Garlich, Joseph R., Morales, Guillermo A., Cho, Yoon J., Bao, Lei, Levy, Michael L., Newbury, Robert, Malicki, Denise, Messer, Karen, Crawford, John, Durden, Donald L.
Publicado 2016

Association of high microvessel α(v)β(3) and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126

por Erdreich-Epstein, Anat, Singh, Alok R., Joshi, Shweta, Vega, Francisco M., Guo, Pinzheng, Xu, Jingying, Groshen, Susan, Ye, Wei, Millard, Melissa, Campan, Mihaela, Morales, Guillermo, Garlich, Joseph R., Laird, Peter W., Seeger, Robert C., Shimada, Hiroyuki, Durden, Donald L.
Publicado 2016